All fees are listed in AUD and include GST. Registration payments via electronic funds transfer will close on Wednesday 16 November 2022.
Thursday 1 December 1200-1300 AEST.
The Charming Squire, 3/133 Grey St, South Brisbane.
Please note, MM2022 will start at 1330 AEST sharp.
RSVPs must be received by Friday 25 November.
Please note: this is at attendee's own expense and is not included in pre-conference or conference registration.
Facilitated by the Aboriginal and Torres Strait Islander Leadership Committee
Thursday 1 December, 10am-1130am AEST
CEOs Boardroom, State Library of Queensland
SHPA Members only
This pre-conference session will place participants in an urban setting on an ancient landscape criss-crossed by modern versions of ageing Aboriginal pathways and gathering places.
Participants will experience a guided mental stripping back of the landscape surrounding the Talking Circle and Brisbane Convention and Exhibition Centre and an introduction to the stories, relationships and places that continue to shape the lives of the world’s oldest consumers, carers, and community networks.
This guided opening provides the setting for ceremonially opening the Yarning Circle and hearing from Brisbane Aboriginal and Torres Strait Islander community members about their lived consumer experiences of a hybrid health system that struggles with understanding The Gap let alone Closing the Gap.
The 90-minute Constellation of Care yarning experience may challenge personal conceptions of partnerships and the act of partnering… the why, how and for who - so what?
Participants will have enhanced understanding of:
Weather permitting, part of this session will involve a walk from the State Library of Queensland Talking Circle to the Brisbane River.
| SHPA members only | $25 |
Please note, morning tea is not included
Facilitated by the Emergency Medicine Leadership Committee
Thursday 1 December, 0900-1130am AEST
A practical skills workshop dedicated to the essential components of resuscitation and how a clinical pharmacist can have a positive impact in critically unwell patient presentations to the Emergency Department and in the management of patient deterioration. Participants will be supported through various simulation scenarios which includes management of a patient during cardiac arrest. An essential session for any pharmacist wanting to improve their confidence in up-front decision making, knowledge translation on the clinical priorities and application of the unique skillset of pharmacists in resuscitation.
| Type | Early bird rate* (closes 27 October) | Standard rate |
| SHPA member | $80 | $100 |
| Non-member | $105 | $125 |
Morning tea included, lunch is not included.
*Payment must be received by 27 October 1159pm AEDT for the early bird rate to apply.
This activity has been accredited for 2hrs of Group 2 CPD (or 4 CPD credits), suitable for inclusion in an individual pharmacist's CPD plan. The accreditation number is S2022/84.
The program addresses pharmacist competency standards*, including:
Standard 3.1.2 Assess medication management practices and needs
Standard 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber
Standard 3.3.1 Undertake a clinical review
Standard 3.3.2 Apply clinical review findings to improve health outcomes
*National Competency Standards Framework for Pharmacists in Australia, 2016
| Time (AEST) | Session |
| 0900-0910 | Welcome, introduction and housekeeping |
| 0910-1010 | Case simulation: Cardiac arrest |
| 1010-1030 | Morning Tea |
| 1030-1130 | Case simulation: Status epilepticus |
| 1130 | Close of pre-conference session |
Elizabeth Doran, Lead Pharmacist – Emergency and Trauma Centre, Royal Brisbane Women’s Hospital, Brisbane, Qld
Elizabeth Currey, Emergency Medicine Pharmacist and Acting Deputy Director of Pharmacy (Clinical), Princess Alexandra Hospital, Brisbane, Qld
Amy Thomson, Deputy Director, NSW Poisons Information Centre, Sydney, NSW
Facilitated by the Mental Health Leadership Committee
Thursday 1 December, 9am-1230pm
With escalating rates of anxiety, depression, eating disorders and mental distress throughout the coronavirus pandemic, there has never been a more important time to focus on innovation in the treatment of mental health.
This pre-conference session will look at the future of mental health treatment, across the lifespan.
| Type | Early bird rate* (closes 27 October) | Standard rate |
| SHPA member | $130 | $150 |
| Non-member | $170 | $190 |
Morning tea included, lunch is not included.
*Payment must be received by 27 October 1159pm AEDT for the early bird rate to apply.
This activity has been accredited for 2 hours of Group-1 CPD and 1 hour of Group-2 CPD (for a total of 4 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2022/87.
The program addresses the pharmacist competency standards*, including:
Standard 3.1.2 Assess medication management practices and needs
Standard 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber
Standard 3.3.1 Undertake a clinical review
Standard 3.3.2 Apply clinical review findings to improve health outcomes
Standard 3.5.2 Promote evidence-based medicine use
Standard 4.7.2 Support and assist implementation of healthcare priorities
Standard 5.1.2 Conduct education and training consistent with educational practice
Standard 5.3.2 Retrieve relevant information/evidence in a timely manner
*National Competency Standards Framework for Pharmacists in Australia, 2016.
| Time (AEST) | Session |
| 0900-0905 | Welcome and introduction |
| 0905-1000 | Youth Mental Health & Climate Change A/Prof Fiona Charlson, Principal Research Fellow, Queensland Centre for Mental Health Research, Brisbane, Qld |
| 1000-1030 | Case Study: Adolescent Mental Health Presenter TBC Luke Lanham, Pharmacist, Toowoomba Hospital, Toowoomba; PhD Candidate, School of Pharmacy, University of Queensland, Brisbane, Qld |
| 1030-1100 | Morning tea |
| 1100-1140 | New developments in psychopharmacotherapy Luke Lanham, Pharmacist, Toowoomba Hospital, Toowoomba; PhD Candidate, School of Pharmacy, University of Queensland, Brisbane, Qld |
| 1140-1200 | Advanced Training Residency in Mental Health Philippa Scott, Mental Health Pharmacist, Princess Alexandra Hospital, Brisbane, Qld |
| 1200-1230 | Older persons case study Philippa Scott, Mental Health Pharmacist, Princess Alexandra Hospital, Brisbane, Qld |
Facilitated by the Medication Safety Leadership Committee
Thursday 1 December, 9:30am-12:30pm AEST
In this interactive session, participants will have the opportunity to:
| Type | Early bird rate* (closes 27 October) | Standard rate |
| SHPA member | $50 | $70 |
| Non-member | $65 | $85 |
Morning tea included, lunch is not included.
*Payment must be received by 27 October 1159pm AEDT for the early bird rate to apply.
This activity has been accredited for 1.5hrs of Group 1 CPD and 1hr of Group 2 CPD (for a total of 3.5 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2022/86.
The program addresses the pharmacist competency standards*, including:
Standard 3.5.1 Review trends in medicine use
Standard 3.5.2 Promote evidence-based medicine use
Standard 4.3.2 Foster initiative and contribute to innovation, improvement and service development
Standard 4.7.1 Understand and contribute to organisational/corporate and clinical governance
*National Competency Standards Framework for Pharmacists in Australia, 2016.
| Time (AEST) | Session | |
| 0930-0935 | Welcome & Introduction | |
| 0935-1035 | Medication Safety MythBusters | |
| 1035-1105 | From Clinical Incident Review to Quality Improvement | |
| 1105-1125 | Morning Tea | |
| 1125-1225 | Facilitated Group Discussion: What medication safety concerns keep you up at night and what we can do about them? | |
| 1225-1230 | Closing remarks |
Toni Howell, Medication Safety and Strategy Pharmacist, St Vincent’s Hospital, Melbourne, Vic
Wendy Ewing, Deputy Director of Pharmacy – Quality, Monash Health, Melbourne, Vic
Kerry Fitzsimons, Manager, Medicines and Technology Unit, Department of Health, Perth, WA
Chris Giles, Deputy Director, Pharmacy Practice Unit, Icon Group Pharmacy Services, Brisbane, Qld
Linda Graudins, Medication Safety Lead, Alfred Health, Melbourne, Vic
Nam-Anh Nguyen, Medicines Management Pharmacist, WA Country Health Service, Perth, WA
Bonnie Tai, Brisbane, Qld
Facilitated by the Paediatrics and Neonatology Leadership Committee
Thursday 1 December, 9am-12pm AEST
This advanced workshop for Paediatrics and Neonates will cover topical areas, including:
The workshop will also provide an opportunity for some pharmacists to present their research or initiative for paediatric and neonatal population as lightning talks.
There will be opportunity for group discussions and sharing ideas from your daily practice for others to learn from and adopt if possible.
| Type | Early bird rate* (closes 27 October) | Standard rate |
| SHPA member | $50 | $70 |
| Non-member | $65 | $85 |
Morning tea included, lunch is not included.
*Payment must be received by 27 October 1159pm AEDT for the early bird rate to apply.
This activity has been accredited for 2.75hrs of Group 1 CPD (or 2.75 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2022/85.
The program addresses the pharmacist competency standards*, including:
Standard 3.1.2 Assess medication management practices and needs
Standard 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber
Standard 4.2.2 Plan and prioritise work
Standard 4.2.3 Maintain productivity
Standard 4.7.6 Work across service delivery boundaries
Standard 5.1.2 Conduct education and training consistent with educational practice
*National Competency Standards Framework for Pharmacists in Australia, 2016.
| Time | Session |
| 0900-0905 | Welcome and introduction Sonya Stacey, Director of Pharmacy, Children’s Health Queensland Hospital and Health Service, Brisbane, Qld |
| 0905-0915 | Clinical practice: patient prioritisation Prioritisation tool: development and maintenance Dr Alka Garg, Deputy Director of Pharmacy, Women’s and Children’s Hospital, SA Pharmacy, Adelaide, SA |
| 0915-0925 | Clinical prioritisation: exceptions to the rule Heidi Wong, Pharmacist Clinical Lead (Medical), Children’s Health Queensland Hospital and Health Service, Brisbane, Qld |
| 0925-0935 | Patient prioritisation: local practices Open discussion |
| 0935-0940 | Personalised medicines for little people What is personalised medicine? Sonya Stacey, Director of Pharmacy, Children’s Health Queensland Hospital and Health Service, Brisbane, Qld |
| 0940-0945 | Personalising medicine for individual drug handling: busulfan and BMT Rachael Lawson, Pharmacist Clinical Lead (Oncology), Children’s Health Queensland Hospital and Health Service, Brisbane, Qld |
| 0945-0955 | Personalising medicine for the disease: cancer and PRISM study Rachael Lawson, Pharmacist Clinical Lead (Oncology), Children’s Health Queensland Hospital and Health Service, Brisbane, Qld |
| 0955-1005 | Morning tea |
| 1005-1015 | Personalising medicine in critical care - Anti-infectives in PICU, ECMO and RRT Michele Cree, Pharmacist Clinical Lead (Critical Care), Children’s Health Queensland Hospital and Health Service, Brisbane, Qld |
| 1015-1025 | Personalising medicine at a cellular level (CFTR modulators) Carol La Vanda, Senior Pharmacist, Women’s and Children’s Hospital, SA Pharmacy, Adelaide, SA |
| 1025-1035 | Personalising medicine with gene therapy (the Spinal Muscular Atrophy story) Associate Professor Michelle Farrar, Associate Professor in Paediatric Neurology, University of New South Wales; Paediatric Neurologist, Sydney Children’s Hospital, Sydney, NSW |
| 1035-1045 | Questions and discussion |
| 1045-1140 | Lightning talks: research, service improvement, leadershi Facilitated by Natalie Tasker, A/Deputy Director of Pharmacy, Children’s Health Queensland Hospital and Health Service, Brisbane, Qld |
| 1140-1145 | Education and training: SHPA Paediatric learning modules Sonya Stacey, Director of Pharmacy, Children’s Health Queensland Hospital and Health Service, Brisbane, Qld |
| 1145-1155 | Education and training: local practices |
| 1155-1200 | Close Dr Alka Garg, Deputy Director of Pharmacy, Women’s and Children’s Hospital, SA Pharmacy, Adelaide, SA |
Facilitated by the Oncology and Haematology Leadership Committee
Thursday 1 December, 9am-12:30pm AEST
This pre-conference session will inform on various specialist aspects for delivering best practice cancer therapy.
An introduction to Precision Medicine Programs in cancer will facilitate discussion on the feasibility of such programs in daily practice. Therapeutic Drug Monitoring specific to cancer therapies will be explored, with the opportunity to test your knowledge via interactive cases. How to tackle dosing challenges, such as in extremes of BSA, will be demonstrated with the newest recommendations and available resources highlighted. The principles and resources relevant to managing patients on haemodialysis who require chemotherapy or immunotherapy will be presented with related short cases.
| Time | Early bird rate* (closes 27 October) | Standard rate |
| SHPA member | $130 | $150 |
| Non-member | $170 | $190 |
Morning tea included, lunch is not included.
*Payment must be received by 27 October 1159pm AEDT for the early bird rate to apply.
This activity has been accredited for 1.5 hours of Group-1 CPD and 1.5 hours of Group-2 CPD (for a total of 4.5 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2022/88.
The program addresses the pharmacist competency standards*, including:
Standard 3.1.2 Assess medication management practices and needs
Standard 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber
Standard 3.3.1 Undertake a clinical review
*National Competency Standards Framework for Pharmacists in Australia, 2016.
| Time (AEST) | Session |
| 0900-0905 | Welcome and introduction |
| 0905-0950 | Session 1 - Precision Medicine Programs in cancer Hayley Vasileff, Statewide Lead Cancer Services Pharmacy, SA Pharmacy, South Australia |
| 0950-1030 | Session 2 - Therapeutic Drug Monitoring in cancer Shaun O'Connor, Senior Cancer Services Pharmacist, St Vincent's Public Hospital Melbourne Senior Project Officer, Department of Health, Victoria |
| 1030-1100 | Morning tea |
| 1100-1145 | Session 3 - Dosing challenges : renal function, when/whether to adjust for high/low BSA, obesity Amanda Tey, Senior Haematology pharmacist, Monash Health, Victoria Special Medicine pharmacy team leader, Monash Health, Victoria |
| 1145-1230 | Session 4 - How to manage haemodialysis and cancer therapy (chemotherapy/immunotherapy) John Coutsouvelis, Senior Clinical Pharmacist (Cancer and Medical Specialties), The Alfred Hospital, VIC; Senior Clinical Lecturer (adjunct), Monash University, VIC |
| 1230 | Pre-conference session close |
Morning tea included, lunch is not included.
*Payment must be received by 27 October 1159pm AEDT for the early bird rate to apply.
Register today for Medicines Management 2022.
SHPA Members get up to $500 off registration!
